AMCP Annual Meeting 2025

Certara’s Market Access Pricing and Reimbursement Consulting services empower global and U.S. market access teams to achieve strategic success. By optimizing product value, positioning, and evidence synthesis, we ensure your product’s value is effectively demonstrated across all stages of the reimbursement journey.

前臨床

• Candidate drug selection
• Comparator in clinical trials
• Market potential assessment
• Market landscape assessment (ongoing through all phases)

Early Clinical (Phase I and II)

• Clinical trial design input
• Go/no-go decisions on continued product development
• Indication prioritization
• First price scenarios
• Pricing/reimbursement barriers
• Initial segmentation

Late Clinical (Phase III and Launch Prep)

• Payer value story and messaging
• Global pricing strategy
• Launch sequence
• Pricing, contracting and rebate strategy
• Global value/AMCP dossier
• Support material for regions/affiliates

Post-Launch (Lifecycle Management)

• Indication expansion
• Biosimilar/generic entry
• Price changes
• Ongoing contract/rebate strategy
• Entry to new markets
• New formulation or device

Brochure – Market Access, Pricing & Reimbursement Services

White Paper – Evaluating the IRA’s Impact on Medicare Part B Biosimilar Reimbursement

Blog – CMS Cell and Gene Therapy (CGT) Access Model Explained

White Paper – Launching a Rare Oncology Product: Comparing Successful Strategies in the U.S. vs Europe

Stop by Booth #615 to speak with members of our team about the latest industry trends and upcoming projects.